Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KAT7 pseudogene 1 is a processed pseudogene located on the X chromosome (Xq21.33), annotated as KAT7P1. Unlike the protein-coding KAT7 gene—which encodes a histone acetyltransferase involved in chromatin regulation and cell cycle control—KAT7P1 is classified as a pseudogene and is not translated into a functional protein, nor does it have known biological function or disease association. It is not regarded as a therapeutic target and is only of genomic interest as a non-coding remnant of the ancestral KAT7 gene. KAT7P1 should not be confused with the functional KAT7 gene or its protein product, which is a histone acetyltransferase enzyme implicated in transcriptional regulation and DNA replication. KAT7P1 is a non-coding pseudogene, not a functional molecule, enzyme, or receptor. It has no role as a drug target, biomarker, or disease gene, and is not relevant for therapeutic intervention. No drugs, mechanisms, or safety considerations are associated with KAT7P1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on KAT7 pseudogene 1 (KAT7P1).